Revolution Medicines News

Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)

TipRanksApr 19 07:30 ET

Oppenheimer Sticks to Their Buy Rating for Revolution Medicines (RVMD)

TipRanksApr 12 07:47 ET

Revolution Medicines Receives Buy Rating Amid Promising Cancer Treatment Data and Expanded Market Opportunities

TipRanksApr 12 06:26 ET

Revolution Medicines Analyst Ratings

BenzingaApr 12 06:14 ET

Revolution Medicines Analyst Ratings

BenzingaApr 10 13:16 ET

Revolution Medicines Analyst Ratings

BenzingaApr 8 07:06 ET

Revolution Medicines' Robust Cancer Drug Pipeline Justifies Buy Rating

TipRanksApr 8 06:35 ET

Revolution Medicines Analyst Ratings

BenzingaMar 11 06:00 ET

Buy Rating on Revolution Medicines Amid Promising RMC-6236 Trials for Multiple Cancer Treatments

TipRanksMar 11 05:05 ET

Revolution Medicines Analyst Ratings

BenzingaMar 8 06:37 ET

Revolution Medicines (RVMD) Receives a Buy From TD Cowen

TipRanksMar 7 07:15 ET

Buy Rating Affirmed for Revolution Medicines: Advancing RAS Inhibitors and Strong Financial Outlook

TipRanksFeb 27 23:36 ET

Revolution Medicines Analyst Ratings

BenzingaFeb 27 08:51 ET

Analysts Are Bullish on Top Healthcare Stocks: Celldex (CLDX), Revolution Medicines (RVMD)

TipRanksFeb 27 08:30 ET

Wedbush Adjusts Revolution Medicines' Price Target to $42 From $41, Keeps Outperform Rating

MT NewswiresFeb 27 06:48 ET

TD Cowen Sticks to Their Buy Rating for Revolution Medicines (RVMD)

TipRanksFeb 26 22:35 ET

Revolution Medicines Analyst Ratings

BenzingaJan 16 07:48 ET

B of A Securities Upgrades Revolution Medicines to Buy, Announces $34 Price Target

BenzingaJan 5 08:02 ET

Revolution Medicines Analyst Ratings

BenzingaJan 5 08:01 ET

Wedbush Starts Revolution Medicines With Outperform Rating, $41 Price Target

MT NewswiresJan 4 07:15 ET